{
  "id": 1769615758338,
  "seqId": 156,
  "title": "Orbital Tumours & Vascular Lesions: The Complete Clinical Compendium",
  "summary": "An exhaustive clinical guide detailing the epidemiology, clinical features, investigations, and management of orbital neoplasms and vascular anomalies including lacrimal, neural, lymphoproliferative, and metastatic conditions.",
  "date": "2026-01-28T15:55:58.338Z",
  "data": {
    "title": "Orbital Tumours & Vascular Lesions: The Complete Clinical Compendium",
    "summary": "An exhaustive clinical guide detailing the epidemiology, clinical features, investigations, and management of orbital neoplasms and vascular anomalies including lacrimal, neural, lymphoproliferative, and metastatic conditions.",
    "summary_illustration": "<svg viewBox='0 0 200 200' xmlns='http://www.w3.org/2000/svg'><circle cx='100' cy='100' r='80' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='4'/><path d='M60 100 Q100 40 140 100 Q100 160 60 100' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='4'/><circle cx='100' cy='100' r='15' fill='hsl(215, 90%, 45%)'/><path d='M140 60 L170 30 M140 140 L170 170 M60 60 L30 30' stroke='hsl(215, 90%, 45%)' stroke-width='3'/></svg>",
    "sections": [
      {
        "title": "Lacrimal Gland: Pleomorphic Adenoma (Benign Mixed Cell Tumour)",
        "icon": "visibility",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "center": "Pleomorphic Adenoma",
          "branches": [
            "Epidemiology: Commonest lacrimal neoplasm (up to 20% of fossa lesions). Middle age, slight male bias (♂:♀ 1.5:1).",
            "Origin: Derived from epithelial and mesenchymal tissue. Arises from either lobe, most commonly the orbital lobe.",
            "Malignant Transformation: <3% in 10y; 10–20% in 20y.",
            "Clinical Features: Gradual painless inferonasal proptosis, upper lid swelling, diplopia, palpable mass (orbital lobe tumours may not be palpable). Globe indentation: choroidal folds ± hypermetropic shift."
          ]
        }
      },
      {
        "title": "Pleomorphic Adenoma: Investigations & Treatment",
        "icon": "biotech",
        "type": "table",
        "layout": "half_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Modality",
            "Findings / Management"
          ],
          "rows": [
            [
              "US",
              "Round, lobulated lesion, typically medium/high reflectivity."
            ],
            [
              "CT/MRI",
              "Expansion of lacrimal fossa, globe indentation, well-circumscribed/nodular, calcification (3%)."
            ],
            [
              "Surgery",
              "Removal of whole tumour with intact pseudocapsule without prior biopsy (risk of seeding). Anterior (palpebral) or lateral (orbital) orbitotomy."
            ],
            [
              "Prognosis",
              "Excellent with complete excision. Warn regarding KCS. Prolonged follow-up needed for malignant transformation."
            ]
          ]
        }
      },
      {
        "title": "Lacrimal Carcinomas: High Alert",
        "icon": "warning",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Commonest malignant: Adenoid cystic carcinoma, followed by mucoepidermoid and pleomorphic adenocarcinoma.",
          "Clinical: Rapid proptosis, ophthalmoparesis, orbital pain, or sensory disturbance from perineural spread.",
          "Imaging: Irregular poorly defined lesion, bony destruction, calcification (20–30%).",
          "Treatment: Seldom curative; exenteration ± radiotherapy.",
          "Prognosis: Very poor with high mortality."
        ]
      },
      {
        "title": "Neural Tumours: Optic Nerve Glioma",
        "icon": "psychology",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "Uncommon slow-growing glial tissue tumour; usually occurs in children.",
          "Strong association with Neurofibromatosis-1 (NF-1).",
          "Presentation: Gradual dVA (often stabilizes), disc swelling or atrophy, and proptosis.",
          "Distribution: Isolated nerve (22%), Chiasm (72%), often involves midbrain/hypothalamus.",
          "Imaging: Fusiform enlargement of optic nerve ± chiasmal mass.",
          "Observation: For isolated nerve tumours distant from chiasm, good vision, non-disfiguring proptosis. Monitor with serial MRI.",
          "Surgical Excision: For reduced vision, pain, severe proptosis, or posterior spread threatening chiasm.",
          "Other Tx: Chemotherapy or radiotherapy for chiasmal/midbrain involvement.",
          "Prognosis: Good for nerve-restricted; worsens with posterior involvement."
        ]
      },
      {
        "title": "Neural Tumours: Meningioma & Schwannoma",
        "icon": "neurology",
        "type": "table",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Feature",
            "Optic Nerve Sheath Meningioma",
            "Schwannoma"
          ],
          "rows": [
            [
              "Type",
              "Rare benign (meningothelial cells). Middle age. ♀:♂ 1.5:1.",
              "Uncommon slow-growing (peripheral/cranial nerves). Benign/Malignant."
            ],
            [
              "Associations",
              "Neurofibromatosis-2.",
              "Neurofibromatosis."
            ],
            [
              "Presentation",
              "Gradual dVA, disc swelling/atrophy, disc collateral vessels (30%), proptosis, ophthalmoparesis.",
              "Adulthood. Superior orbit. Non-tender mass (often cystic), proptosis, dVA, restricted motility."
            ],
            [
              "Imaging",
              "Tubular enlargement; ‘tram-track’ enhancement ± calcification.",
              "N/A"
            ],
            [
              "Treatment",
              "Observation if VA good. Excision for blind eyes, severe proptosis, or chiasm threat.",
              "Complete surgical excision."
            ],
            [
              "Prognosis",
              "Life: Good.",
              "Good."
            ]
          ]
        }
      },
      {
        "title": "Neurofibroma Variants",
        "icon": "account_tree",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Plexiform Neurofibroma: Childhood onset, strongly associated with NF-1. 'Bag-of-worms' mass with S-shaped lid deformity. Poorly defined, not encapsulated. Surgery: difficult, may need repeated debulking.",
          "Isolated Neurofibroma: Adulthood onset, gradual proptosis. Well-circumscribed. Surgery: usually straightforward."
        ]
      },
      {
        "title": "Vascular: Cavernous Haemangioma",
        "icon": "bloodtype",
        "type": "mindmap",
        "layout": "half_width",
        "color_theme": "red",
        "content": {
          "center": "Cavernous Haemangioma",
          "branches": [
            "Type: Commonest benign orbital neoplasm in adults. Hamartoma of large vascular spaces.",
            "Presentation: Young adulthood, accelerated in pregnancy. Usually intraconal (80%).",
            "Clinical: Axial proptosis, restricted motility, globe indentation (choroidal folds/hypermetropic shift), dVA. Rare: amaurosis.",
            "Investigations: US (well-defined, high internal reflectivity). CT/MRI (intraconal, mild/mod enhancement, possible thrombosis).",
            "Treatment: Observation for asymptomatic; excision for symptomatic."
          ]
        }
      },
      {
        "title": "Vascular: Capillary Haemangioma",
        "icon": "child_care",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "red",
        "content": [
          "Definition: Hamartoma. Massive tumours may cause Kasabach-Merritt syndrome (dplatelets, dhb, dclotting factors) or high-output cardiac failure.",
          "Superficial ('Strawberry Naevus'): Confined to dermis. Bright red, appears <2mo, full size by 1y, involutes by 6y. May cause amblyopia/astigmatism.",
          "Deep Lesions: Posterior to septum. Variable proptosis (worsens with Valsalva/crying). Partial involution with time.",
          "Treatment: Topical/intralesional/systemic corticosteroids, Systemic propranolol, Surgical excision."
        ]
      },
      {
        "title": "Vascular: Lymphangioma",
        "icon": "water_drop",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "blue",
        "content": "A rare hamartoma of lymph vessels presenting in childhood. Size increases with head-down posture or Valsalva. Superficial: transilluminable cystic spaces (lid/conjunctiva) ± blood. Deep: gradual proptosis or acute pain/dVA due to haemorrhage (‘chocolate cyst’). CT shows low-density cyst-like mass and orbital enlargement. Treatment: Observation, sclerosing agents, bleomycin, Onyx® (ethylene-vinyl-alcohol co-polymer), surgery, or drainage of sight-threatening bleeds. Surgery is difficult (large/friable)."
      },
      {
        "title": "Lymphoproliferative Diseases",
        "icon": "groups",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Range: Benign hyperplasia to malignant lymphoma (85% B-lymphocytes). Classified by WHO system.",
          "Benign Reactive Lymphoid Hyperplasia: Polyclonal, superolateral orbit (lacrimal gland). Gradual proptosis, ptosis, firm mass. Tx: Steroids, radiotherapy, rituximab. 25% progress to lymphoma in 5y.",
          "Atypical Lymphoid Hyperplasia: Intermediate. Homogeneous pattern with larger nuclei.",
          "Malignant Orbital Lymphoma: Low-grade B-cell (Non-Hodgkin’s). Commonest: Marginal zone B-cell lymphoma of MALT (40–70%). Bilateral in 25%. Systemic involvement in 40% (diagnosis) to 60% (5y). Tx: Radiotherapy, chemo, monoclonal antibodies."
        ]
      },
      {
        "title": "Langerhans Cell Histiocytosis",
        "icon": "escalator_warning",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Rare childhood proliferative disorder.",
          "Spectrum: Benign unifocal 'Eosinophilic Granuloma' to disseminated 'Letterer–Siwe'.",
          "Eosinophilic Granuloma: Orbital involvement common; rapid proptosis with superotemporal swelling.",
          "Letterer-Siwe: May cause bilateral proptosis.",
          "Treatment: Surgical excision is usually curative."
        ]
      },
      {
        "title": "Rhabdomyosarcoma: Pediatric Emergency",
        "icon": "emergency",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Commonest 1° orbital malignancy in children; 87% present before 15y (♂ bias 1.6:1).",
          "Histology: Embryonal (commonest), Alveolar, Pleomorphic. Pluripotent mesenchymal origin.",
          "Location: Intraconal (50%) or superior orbit (25%).",
          "Clinical: Acute/subacute proptosis, ptosis, inflammation (mimics orbital cellulitis).",
          "Imaging: US (irregular, well-defined, low/med reflectivity, high Doppler flow); CT/MRI (irregular mass ± bony erosion).",
          "Management: Biopsy + Systemic work-up mandatory. Surgery for localized; Combined Radio+Chemo for extensive."
        ]
      },
      {
        "title": "Fibrous Histiocytoma & Metastases",
        "icon": "clinical_notes",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Condition",
            "Details"
          ],
          "rows": [
            [
              "Fibrous Histiocytoma",
              "Commonest adult mesenchymal orbital tumour. Middle-aged or children post-radiotherapy. Benign or malignant. Located superonasally. Gradual proptosis, pain, dVA, restricted motility. Tx: Complete excision. Recurrence common."
            ],
            [
              "Orbital Metastases",
              "Uncommon. In 50% cases, precede diagnosis of primary tumour. Aggressive: rapid proptosis, restricted motility, CN involvement, inflammation."
            ],
            [
              "Metastases: Adults",
              "Breast, Lung, Prostate, GI. Scirrhous (Breast/Gastric) may cause enophthalmos."
            ],
            [
              "Metastases: Children",
              "Neuroblastoma, Nephroblastoma, Ewing sarcoma."
            ]
          ]
        }
      },
      {
        "title": "Vascular Lesions: Orbital Varices",
        "icon": "analytics",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Definition: Uncommon congenital venous enlargements (medial orbit, usually unilateral).",
          "Clinical: Intermittent proptosis/visible varix (worsens with Valsalva/coughing/head-down). Possible thrombosis/haemorrhage.",
          "Investigations: CT/MRI show multiple masses, orbital wall expansion, and phleboliths.",
          "Treatment: Surgery (difficult) if painful/disfiguring/sight-threatening. Radiological endovascular sclerosant/coil possible."
        ]
      },
      {
        "title": "AV Fistula: Carotid–Cavernous & Dural Shunt",
        "icon": "hub",
        "type": "table",
        "layout": "full_width",
        "color_theme": "red",
        "content": {
          "headers": [
            "Feature",
            "Carotid–Cavernous Fistula (Direct)",
            "Dural Shunt (Indirect CCF)"
          ],
          "rows": [
            [
              "Flow Type",
              "High-flow: Direct ICA to Cavernous Sinus.",
              "Low-flow: Dural arteries to Cavernous Sinus."
            ],
            [
              "Etiology",
              "Trauma (young adults) or spontaneous (hypertension/elderly).",
              "Congenital (Wyburn-Mason) or spontaneous."
            ],
            [
              "Clinical Features",
              "dVA, diplopia, audible bruit, pulsatile proptosis, orbital oedema, chemosis, iIOP, ophthalmoparesis (III/VI), vein engorgement, RAPD, disc swelling, ischemia.",
              "Often asymptomatic; pain, cosmesis, chemosis, episcleral engorgement/arterialization, iIOP."
            ],
            [
              "Imaging (Both)",
              "B-scan/Doppler US, CT, MRI: Dilated superior ophthalmic vein + thickened EOMs.",
              ""
            ],
            [
              "Management",
              "Embolization (success >85%). Visual loss occurs in 50% without Tx.",
              "40% thrombose spontaneously. Tx reserved for glaucoma, dVA, diplopia, or severe pain."
            ]
          ]
        }
      }
    ],
    "chapterId": "orbit"
  },
  "chapterId": "orbit",
  "_newlyImported": 1769615758338,
  "communityId": "sub_1769614749293_xdb3wf052wgxh0",
  "communityAuthor": "hh",
  "communityDate": "2026-01-28T15:39:09.293Z"
}